DBV Technologies Reports First Quarter 2025 Financial Results

Provided By GlobeNewswire

Last update: Apr 30, 2025

Châtillon, France, April 30, 2025

DBV Technologies Reports First Quarter 2025 Financial Results

DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT – CUSIP: 23306J309), a clinical-stage biopharmaceutical company, today reported financial results for the First Quarter of 2025. The quarterly and three months financial statements were approved by the Board of Directors on April 30, 2025.